Molecular upgrading of grade 2 astrocytomas in the era of targeted IDH inhibition: are we ready for the therapeutic consequences?

Quintino Giorgio D’Alessandris, Silvia Chiesa, Marco Gessi; Molecular upgrading of grade 2 astrocytomas in the era of targeted IDH inhibition: are we ready

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2026-09-04
DOI
https://doi.org/10.1093/neuonc/noag215
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular upgrading of grade 2 astrocytomas in the era of targeted IDH inhibition: are we ready for the therapeutic consequences?

Silvia Chiesa, Quintino Giorgio D’Alessandris, Marco Gessi
Neuro-Oncology
Glioma Diagnosis and Treatment
article

Molecular upgrading of grade 2 astrocytomas in the era of targeted IDH inhibition: are we ready for the therapeutic consequences?

Silvia Chiesa, Quintino Giorgio D’Alessandris, Marco Gessi
article en

Abstract

Quintino Giorgio D’Alessandris, Silvia Chiesa, Marco Gessi; Molecular upgrading of grade 2 astrocytomas in the era of targeted IDH inhibition: are we ready

Neuro-Oncology
Università Cattolica del Sacro Cuore (IT), Agostino Gemelli University Polyclinic (IT)
Openalex Percentile: Top 11%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.